alexa Eden Rebecca Padayachee | University of Gothenburg
ISSN: 2168-9296

Cell & Developmental Biology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Eden Rebecca Padayachee

Eden Rebecca Padayachee Eden Padayachee
Department of Neurochemistry
University of Gothenburg

Dr. Eden Rebecca Padayachee is currently a post-doctoral fellow at the Institute of Neuroscience & Physiology in Gothenburg, Sweden. She received her Ph.D in Medicinal Biochemistry from Rhodes University, South Africa and possesses over 5 years of experience in enzymology, amyloid-beta aggregation and biomarker discovery. The title of her dissertation was “biochemical mechanisms of Alzheimer’s disease.” She is a scientific discoverer and innovator and was commented on by a thesis examiner, who said off her “This candidate’s discovery could be very important in the Alzheimer’s field and may be the most impactful result of this work. She should be complimented on her methodological expertise and tenacity.” She was recently selected as one of the top 15 candidates out of 300 to attend a 5 day boot camp at the BioMed-X GmbH in Heidelberg, Germany, targeting tau-mediated neurodegeneration in Alzheimer's disease. Her objective is open up her own pharmaceutical company specializing in biomarker discovery, related to enzymes as biosensors and the use of nanovehicles e.g. endogenous protein or lipid based particles that have regenerative properties. Her hobbies include writing a book entitled “How to become a visionary and be your own catalyst for positive change right now”. She is a master at writing her own powerful quotations to inspire others to reach their full potential.  She has been personally invited as guest speaker at the Alzheimer’s Association, UK; International Woman’s Club, Sweden and neuroscience conferences in South Africa, Thailand, China, America and Denmark, resulting in the creation of a global knowledge hub in Alzheimer’s research and innovative therapeutic strategies.

Research Interest

Dr. Padayachee’s passion is ENZYMES! She absolutely loves figuring out enzyme mechanisms, catalysis, kinetics and their function. As a structural biochemist and enzymologist, she enjoys studying enzyme-ligand binding, by using a suite of computational docking software e.g. AutoDock. Biological thermodynamics, spectroscopy, spectrofluorimetry, surface plasmon resonance, electron microscopy are some of the techniques she has used in studying ligand binding phenomena. She strongly believes that enzyme-ligand binding is the basis for future drug discovery as how proteins bind and their subsequent conformational changes are the keys to unlocking the design of therapeutic agents to target protein misfolding diseases. Amyloid fibrils and neurofibrillary tangles are hall marks of Alzheimer’s disease. In her Ph.D thesis she developed new therapeutic strategies in the diagnosis of Alzheimer’s disease by investigating the potential of the enzyme nitric oxide synthase as a catalyst for amyloid fibril formation. She discovered that nanoparticles reverse amyloid fibril formation. Her current position as a post doctorate focused on identifying high density lipoprotein (HDL) particles in cerebrospinal fluid and its effect on reducing amyloid aggregation in AD. Amyloid beta and Tau has been found to interact and form a complex at the synapse. A small molecule inhibitor that prevents the formation of this complex is ideal. She would like to apply the use of endogenous HDL as a “disaggregating agent" to block this complex from forming in the first instance. Targeting the clearance of Aβ and Tau simultaneously affords a combination therapy approach that could be very promising in the field of AD. She believes that imagination is more creative than knowledge and enjoys stimulating innovative thought in young minds by encouraging scientists to step out of their comfort zone and seek challenges at the interface between academia and industry.


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version